Bolt Biotherapeutics, Inc. (BOLT)
NASDAQ: BOLT · Real-Time Price · USD
3.665
+0.465 (14.53%)
At close: Aug 21, 2026, 4:00 PM EDT
3.660
-0.005 (-0.14%)
After-hours: Aug 21, 2026, 7:14 PM EDT
Bolt Biotherapeutics Stock Forecast
Stock Price Forecast
According to 4 analysts polled by S&P Global, Bolt Biotherapeutics stock has a consensus rating of "Buy" and an average price target of $29. The average 1-year stock price forecast is 691.27% higher than the current stock price, while the lowest is $5.00 (+36.43%) and the highest is $75 (+1,946.38%).
Price Target: $29 (+691.27%)
Analyst Consensus: Buy
Price Target
Chart* Price targets were last updated on May 28, 2026.
Analyst Ratings
The average analyst rating for Bolt Biotherapeutics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Oct '25 | Nov '25 | Mar '26 | Apr '26 | May '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 2 | 2 | 2 | 2 | 2 |
| Buy | 1 | 0 | 0 | 0 | 0 | 0 |
| Hold | 3 | 3 | 1 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 3 | 4 | 4 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| JonesTrading | JonesTrading | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Aug 12, 2026 |
| Rodman & Renshaw | Rodman & Renshaw | Buy Initiates $22 | Buy | Initiates | $22 | +500.27% | May 28, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $7 | Buy | Reiterates | $7 | +91.00% | May 28, 2026 |
| Lake Street | Lake Street | Buy Maintains $75 | Buy | Maintains | $75 | +1,946.38% | May 13, 2026 |
Financial Forecast
Revenue This Year
133.33K
from 7.70M
Decreased by -98.27%
Revenue Next Year
3.50M
from 133.33K
Increased by 2,525.07%
EPS This Year
-26.29
from -17.06
EPS Next Year
-20.19
from -26.29
EPS and Forward PE are based on non-GAAP adjusted numbers.